CMS Energy heads into late August with an unusual tension: short sellers are retreating at speed, yet options traders just turned the most defensive they have been all year.
The options signal is the sharpest data point of the week. The put/call ratio jumped to 0.295 on Tuesday — more than four standard deviations above its 20-day average of 0.10. That is the highest defensive skew CMS has printed in the past year outside of its 52-week peak at 0.64, and the spike arrived in a single session after weeks of PCR readings that barely cleared 0.10. Something prompted a swift, concentrated demand for downside protection. The borrow market tells a quieter version of the same story: cost to borrow doubled overnight on August 25 to 0.89%, its highest level in 30 days, though it remains categorically cheap in absolute terms. Borrow availability is exceptionally loose at 2,099% — meaning the lending pool holds roughly 21 times more shares available than are currently borrowed — so there is no structural squeeze pressure here. The CTB move is a blip, not a trend.
Short interest itself is moving in the opposite direction to the options caution. Bears have been covering steadily: SI has fallen 27% in a month to 5.1% of the free float, with the most recent daily reading down another 6.5% in a single session. That unwind has been consistent and orderly — positions peaked above 21 million shares in early July and have ground lower every week since. The ORTEX short score has also eased to 41.2, down from 44 a week ago, reflecting both the declining SI and improving lending dynamics. The overall picture in the lending market looks relaxed rather than charged.
The Street has been trimming targets across the board, though most firms are holding positive ratings. Morgan Stanley cut its target by $1 to $79 while maintaining Equal-Weight — a marginal move, but notable as the latest action from a bellwether name. Earlier in the month, Truist cut from $85 to $81 and BMO trimmed from $86 to $82, both keeping Buy-equivalent ratings. The consensus mean sits at $79.58, implying about 16% upside to Tuesday's close of $68.74. Valuation multiples have eased modestly: the PE has shed 0.67 of a turn over 30 days to 17.6x, and EV/EBITDA has drifted down to 11.1x. One factor score genuinely stands out — forward EPS growth ranks in the 94th percentile across the universe, a number that anchors the bull case around above-average regulated earnings compounding. The dividend score ranks 89th percentile, providing a yield floor for income-oriented holders. Bears point to rate-base growth slowing, monetary policy headwinds, and IRA-repeal risk for the NorthStar Clean Energy segment.
The stock is down 3.3% on the week and 8% over the past month to $68.74, underperforming close peers that also sold off but by less. WEC fell 3.9% on the week and CNP dropped 4.0%, so CMS is not alone, but its monthly drawdown is sharper than most in the group. ED lost only 1.9% over the same five sessions, suggesting more defensive positioning into that name. Recent earnings prints offer a modest historical reference: the July 28 Q2 result produced a flat 1-day reaction before a 3.4% five-day drift lower, and the prior print in late July 2026 similarly faded after the initial session. The pattern points to print-day stability followed by a grinding drift, not a sharp gap.
The next earnings event is pencilled in for October 29. Between now and then, the most useful signal to track is whether Tuesday's options spike was a one-day artefact or the start of a sustained build in put demand — if the PCR stays elevated into September, it would suggest the defensive tone extends beyond a single session's hedging flow.
See the live data behind this article on ORTEX.
Open CMS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
